Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promotor-hypermethylation – the NCT Neuro Master Match (N²M²) pilot study.

Pfaff E, Kessler T, Balasubramanian GP, Berberich A, Schrimpf D, Wick A, Debus J, Unterberg A, Bendszus M, Herold-Mende C, Capper D, Schenkel I, Eisenmenger A, Dettmer S, Brors B, Platten M, Pfister SM, von Deimling A, Jones DTW, Wicke W, Sahm F.

Neuro Oncol 2018;20: 826 – 837